SCHEMBL26929241

SCHEMBL26929241

C=C(CC(=O)OC1(c2ccc(S(F)(F)(F)(F)F)cc2)CCC1)C(=O)OCC(=O)O

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ PDE2A O00408 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26929350 0.89 — —
SCHEMBL24397784 0.87 OPRM1 (0.32) PDE2A
SCHEMBL26929222 0.86 — —
SCHEMBL26941609 0.85 ALDH1A1 (0.37) —
SCHEMBL26941610 0.85 MAPK1 (0.36) —
SCHEMBL26941611 0.85 ALDH1A1 (0.37) —
SCHEMBL26942730 0.84 PPARD (0.36) PDE2A
SCHEMBL24394153 0.84 ALDH1A1 (0.37) —
SCHEMBL26941636 0.83 MAPT (0.39) —
SCHEMBL24393978 0.83 PDE2A (0.37) PDE2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230399289-A1 ITACONIC ACID DERIVATIVES SITRYX THERAPEUTICS LIMITED (GB) 2023-12-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230399289-A1 ITACONIC ACID DERIVATIVES IL1R1, LRBA, HCAR1 PDE2A 2531/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback